Keros Therapeutics, Inc. - common stock (KROS) analyst actions
Rating and price-target actions on KROS in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the KROS overview →
2 measured KROS analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Keros Therapeutics, Inc. (KROS) And Encourages Stockholders to Reach Out | Press release | +0.05% | +3.09% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Keros Therapeutics, Inc. (KROS) And Encourages Shareholders to Reach Out | Press release | -1.01% | -2.73% |
Keep exploring
More KROS: earnings → · SEC filings → · KROS overview →